Hospital San Giovanni Battista - Molinette
Torino, 10100, Italy
NCT Number: NCT01406093
A timing diagnosis of candidemia is as important as the correct choice of empiric or targeted antifungal therapy. In the last years a growing body of knowledge has better characterized health-care associated (HCA) infections, which have been described in 2002 in outpatients with MRSA bloodstream infections. So far there is no compelling evidence that patients with HCA infections may develop candidemia before the usual timing of around 20-25 days after admission. Risk factors associated with HCA infections are represented by admission from long term chronic care facilities (LTCF), haemodialysis, previous admission or parenteral broad spectrum antibiotics. There are few data HCA features and early onset candidemias in the published literature.
In this proposal, the investigators aim at studying early-onset candidemia in a retrospective study in one of the largest referral hospital in Italy with a consistent range of specialties ranging (bone marrow transplant, solid organ transplant, immunosuppressed patients, ICU, complex surgery). The investigators speculate that patients with candidemia diagnosed within 10 days (early-onset) by the admission have different risk factors and prognosis of those with a late diagnosis.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Torino, 10100, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 30 days
Giovanni Di Perri
Other
Early- and Late-onset Candidemia: A Retrospective Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04979052
Bacterial Infections and Mycoses, Candidemia
Durham, North Carolina, United States
View Trial DetailsNCT04368559
Aspergillus, Bacterial Infections and Mycoses
Birmingham, Alabama, United States
View Trial DetailsNCT07422155
Bacterial Infections and Mycoses, Candidemia
Ljubljana, Slovenia
View Trial DetailsNCT07272915
Aspergillosis Invasive, Bacterial Infections and Mycoses
Vandœuvre-lès-Nancy, France
View Trial Details